Introduction
Most people know that alcohol, cigarettes, and vaping are not health-promoting. What is less well understood is the specific, measurable physiological cost these habits impose — particularly on the systems directly responsible for athletic performance and recovery. Understanding the mechanisms does not moralize; it gives you accurate information to make informed decisions.
How Alcohol Impairs Protein Synthesis, Sleep Quality, and Hormonal Balance
Muscle protein synthesis: A landmark study published in PLoS ONE (Parr et al., 2014) quantified precisely what happens when athletes consume alcohol after training. Following a hard resistance and sprint training session, participants who consumed approximately eight standard drinks had myofibrillar protein synthesis rates reduced by 37% compared to those who consumed protein without alcohol. Even when protein was co-ingested with alcohol, the suppression persisted at around 24% compared to the protein-only condition.
The mechanism is direct: alcohol metabolites interfere with the mTOR signalling pathway, the primary cellular driver of protein synthesis. Translation: the muscle repair and growth you trained hard to stimulate simply does not occur at the required rate. The training still costs you the same stress and fatigue — the returns are chemically blunted.
Sleep architecture: Alcohol is a sedative — it accelerates sleep onset, which many people interpret as a sleep benefit. It is not. Alcohol profoundly disrupts sleep architecture, specifically suppressing REM sleep in the first half of the night and causing sleep fragmentation in the second half as acetaldehyde levels rise. Studies using polysomnography consistently show reductions in overall sleep quality of 24–39% even with moderate alcohol intake (one to two standard drinks).
For athletes, who depend on deep sleep for growth hormone release and REM sleep for motor skill consolidation, this is a double cost: slower physical repair and impaired skill development, even after what feels like a full night of sleep.
Hormonal balance: Alcohol acutely suppresses testosterone production in both men and women, an effect measurable for up to 24 hours following consumption. It also promotes the aromatisation of testosterone to oestrogen and directly inhibits the liver's ability to clear oestrogen, shifting the hormonal balance unfavourably. Regular moderate-to-heavy drinking is associated with significantly lower resting testosterone levels.
Alcohol also elevates cortisol, impairs insulin sensitivity, and promotes fat storage — creating a hormonal environment that is the direct opposite of what training is trying to build.
The Cardiovascular and Respiratory Consequences of Smoking for Athletes
Cigarette smoke contains over 7,000 chemicals, of which several hundred are directly toxic to the cardiovascular and pulmonary systems.
Lung function: Carbon monoxide in cigarette smoke binds to haemoglobin with 200 times greater affinity than oxygen. This dramatically reduces oxygen-carrying capacity — the fundamental currency of aerobic performance. Even passive smoking measurably reduces VO2 max. Active smokers typically show 20–30% reductions in lung function metrics compared to non-smoking peers of equivalent fitness.
Cardiovascular effects: Nicotine causes acute vasoconstriction, elevated blood pressure, and increased resting heart rate — all of which increase cardiovascular workload during exercise. Long-term smoking accelerates atherosclerosis (arterial plaque formation), reduces arterial elasticity, and impairs cardiac output. Smokers have significantly higher rates of exercise-induced cardiovascular events.
Recovery impairment: Carbon monoxide persists in the blood for 4–8 hours after smoking, reducing oxygen delivery during and after training. Smoking also directly impairs angiogenesis (the formation of new blood vessels) — a key component of cardiovascular adaptation — and reduces the regenerative capacity of satellite cells responsible for muscle repair.
The Risks of Vaping for Athletic Performance
Electronic cigarettes have been marketed as a safe alternative to smoking. The evidence increasingly suggests this is a serious oversimplification.
While vaping does eliminate combustion products and reduces carcinogen exposure, it introduces its own physiological hazards:
Endothelial dysfunction: A study in the Journal of Hypertension found that vaping produced acute impairment in microvascular endothelial function — the ability of small blood vessels to dilate in response to increased demand. This directly limits oxygen delivery to exercising muscles.
Nicotine: Most vaping products deliver nicotine — with all the cardiovascular consequences described above, including elevated resting heart rate, increased blood pressure, and reduced arterial compliance.
Lung tissue damage: Vaping causes measurable pulmonary inflammation, reduced ciliary function (impairing airway clearance), and long-term changes to lung tissue that are distinct from but potentially as serious as combustion-related damage.
Unknown long-term effects: Vaping products have only been widely used for approximately 15 years. The long-term consequences of sustained exposure to heated propylene glycol, vegetable glycerin, and flavouring chemicals at the pulmonary level are not yet fully characterised.
Harm Reduction and Practical Strategies
If complete cessation is the goal, the evidence is clear: combined pharmacotherapy (nicotine replacement therapy or varenicline) with behavioural support produces the highest long-term abstinence rates. Cold turkey alone has a 95% relapse rate within 12 months; supported cessation programmes approach 35–40% 12-month abstinence.
For alcohol reduction, the following evidence-backed strategies support meaningful change:
- Remove alcohol from the home environment (the most effective single change)
- Identify the specific triggers for drinking (stress, social pressure, habit) and address them directly
- Schedule alcohol-free days and track them
- Replace the drink ritual with a non-alcoholic alternative that preserves the social or relaxation function
For vaping and smoking reduction, even a 50% reduction in daily cigarette count meaningfully reduces cardiovascular risk. Transitioning from cigarettes to non-nicotine NRT before cessation is a viable intermediate step.
There is no level of alcohol, cigarette, or vaping use that is performance-enhancing. The question is not whether these habits cost you — it is how much you are willing to pay.